Monoamine oxidase inhibitor usage in Hawaii.

Asian J Psychiatr

Department of Psychiatry, John A. Burns School of Medicine, 1356 Lusitana Street, 4th Floor, Honolulu, HI 96813, USA; The Queen's Medical Center, 1301 Punchbowl Street, Honolulu, HI 96813, USA.

Published: December 2010

Objective: Previous studies involving prescriptions of monoamine oxidase inhibitors (MAOIs) have focused on predominantly Caucasian populations with little representation of Asian Americans and Pacific Islanders. The Asian American diet includes tyramine-rich fermented food items. This study describes the characteristics of MAOI prescribing patterns in Hawaii, a state with predominantly Asian Americans and Pacific Islanders.

Methods: Antidepressant usage including MAOIs were identified using a commercial insurance database from Hawaii Medical Service Association, a Blue Cross/Blue Shield subsidiary. Prescriptions from 1999 to 2003 were identified with basic information including ethnicity, age, diagnostic category, morbidity level, and 6 months adherence to MAOIs.

Results: Of the 28,890 patients prescribed antidepressants, seventeen individuals (0.06%, 95% confidence interval 0.03-0.09%) were prescribed MAOIs. MAOIs continue to be seldom used in treatment. There was no significant difference in prescriptions for MAOIs vs. other antidepressants based on ethnicity.

Conclusions: MAOIs are vastly underutilized in all ethnic groups including Asian American and Pacific Islander groups.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajp.2010.08.007DOI Listing

Publication Analysis

Top Keywords

monoamine oxidase
8
asian americans
8
americans pacific
8
asian american
8
maois
6
oxidase inhibitor
4
inhibitor usage
4
usage hawaii
4
hawaii objective
4
objective previous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!